Decheng Capital LLC Aclaris Therapeutics, Inc. Transaction History
Decheng Capital LLC
- $356 Billion
- Q1 2025
A detailed history of Decheng Capital LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 4,041,736 shares of ACRS stock, worth $5.21 Million. This represents 1.73% of its overall portfolio holdings.
Number of Shares
4,041,736
Previous 2,266,667
78.31%
Holding current value
$5.21 Million
Previous $5.62 Billion
10.01%
% of portfolio
1.73%
Previous 1.21%
Shares
2 transactions
Others Institutions Holding ACRS
# of Institutions
112Shares Held
92.9MCall Options Held
35.4KPut Options Held
32K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$18.4 Million17.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$12.4 Million0.03% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$11.5 Million3.69% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.05MShares$6.51 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.97MShares$6.41 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $86M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...